Strain Information | |
---|---|
Image | |
BRC No. | RBRC06357 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | C57BL/6-Msr1<tm1(HBEGF)Mtka> |
Former Common name | CD204-DTR, B6-Msr1/DTR KI |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Masato Tanaka, RIKEN Research Center for Allergy and Immunology in 2011. B6JN/1 ES cells were used. C57BL/6 background. |
Strain description | CD204 (Msr1) DTR knock-in mice. HB-EGF is expressed from CD204 locus. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | CD204-positive monocytes and macrophages ameliorate septic shock by suppressing proinflammatory cytokine production in mice. Uchida Y, Nishitai G, Kikuchi K, Shibuya T, Asano K, Tanaka M Biochem. Biophys. Rep., 23:100791 (2020). 32793817CD204-positive monocytes and macrophages ameliorate septic shock by suppressing proinflammatory cytokine production in mice. Yoshimi Uchida, Gen Nishitai, Kenta Kikuchi, Takumi Shibuya, Kenichi Asano, Masato Tanaka Biochem. Biophys. Rep., 23:100791 (2020). 32793817 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 8 | Frt | ||||
HBB2 | rabbit beta-globin polyA | 8 | HBB2 | ||||
HBEGF | heparin-binding EGF-like growth factor (human) | 8 | HBEGF | ||||
Msr1 | macrophage scavenger receptor 1 | 8 | Msr1 | targeted mutation 1, Masato Tanaka | |||
gb2 | phage T7 gb2 promoter(synthetic) | 8 | gb2 | ||||
neo | neomycin resistance gene (E. coli) | 8 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | human HB-EGF gene cDNA, Rabbit beta-globin polyA, Saccharomyces cerevisiae FRT sites, mouse Phosphoglycerate kinase promoter (PGK promoter), phage T7 gb2 promoter, E. coli Neomycin resistance gene, mouse Msr1 genomic DNA |
Research application | FLP/frt system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biochem. Biophys. Rep., 23:100791 (2020). The recipient shall not distribute the biological resource to others without a written consent from the DEPOSITOR. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR/DEVELOPER (Masato Tanaka and Gen Nishitai), and then include them as co-authors in any publications resulted by the use of the BIOLOGICAL RESOURCE. |
Depositor | Masato Tanaka (Tokyo University of Pharmacy and Life Sciences) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |